Literature DB >> 18004007

Neurocognitive costs and benefits of psychotropic medications in older adults.

John O Brooks1, Jennifer C Hoblyn.   

Abstract

Psychotropic medications are widely used in older adults and may cause neurocognitive deficits. Older adults are at increased risk of developing adverse effects because of age-related pharmacodynamic and pharmacokinetic changes. This article provides a comprehensive review of the undesirable, and at times beneficial, effects of psychotropic medications. The review covers a wide range of medications that impair executive function, memory, and attention, as well as a much smaller group of medications that lead to improved neurocognitive function. Some of the most commonly used psychotropic medications in older adults, namely, antidepressants, sedatives, and hypnotics, are among the drugs that most consistently lead to cognitive impairments. Medications with anticholinergic properties almost invariably lead to neurocognitive dysfunction, despite symptom improvement. The neurocognitive costs and benefits of psychiatric medications should be considered in the context of disease treatment in older adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004007     DOI: 10.1177/0891988707308803

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  14 in total

1.  Exploration of 100 commonly used drugs and supplements on cognition in older adults.

Authors:  Karen R Obermann; John C Morris; Catherine M Roe
Journal:  Alzheimers Dement       Date:  2013-08-15       Impact factor: 21.566

Review 2.  A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.

Authors:  Catherine E Prado; Stephanie Watt; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2018-02-14       Impact factor: 7.444

3.  Antidepressant suppression of non-REM sleep spindles and REM sleep impairs hippocampus-dependent learning while augmenting striatum-dependent learning.

Authors:  Alain Watts; Howard J Gritton; Jamie Sweigart; Gina R Poe
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

4.  Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism.

Authors:  Nobuko Kemmotsu; Catherine C Price; Genko Oyama; Michael S Okun; Kelly D Foote; Laura L S Howe; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2011-01       Impact factor: 3.535

5.  Benzodiazepines and adequacy of initial antidepressant treatment for depression.

Authors:  Paul N Pfeiffer; Dara Ganoczy; Kara Zivin; Marcia Valenstein
Journal:  J Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.153

Review 6.  Psychotropic medication use among older adults: what all nurses need to know.

Authors:  Pamela L Lindsey
Journal:  J Gerontol Nurs       Date:  2009-09       Impact factor: 1.254

7.  Potentially inappropriate medication use in older adults with mild cognitive impairment.

Authors:  Andrea L Weston; Andrea M Weinstein; Cynthia Barton; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-10-20       Impact factor: 6.053

8.  Meeting the Mental Health Needs of the Homebound: A Psychiatric Consult Service Within a Home-Based Primary Care Program.

Authors:  Jennifer M Reckrey; Linday V DeCherrie; Micheline Dugue; Anna Rosen; Theresa A Soriano; Katherine Ornstein
Journal:  Care Manag J       Date:  2015

9.  Epigenetic Alterations Impact on Antipsychotic Treatment in Elderly Patients.

Authors:  Bryan M McClarty; Daniel W Fisher; Hongxin Dong
Journal:  Curr Treat Options Psychiatry       Date:  2018-01-15

10.  Associations Between Trauma, Sleep, and Cognitive Impairment Among Latino and Asian Older Adults.

Authors:  Altaf Saadi; Mario Cruz-Gonzalez; Andrew Hwang; Lauren Cohen; Margarita Alegria
Journal:  J Am Geriatr Soc       Date:  2021-01-05       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.